McKesson (MCK)
(Delayed Data from NYSE)
$543.30 USD
+3.36 (0.62%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $543.18 -0.12 (-0.02%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth B Momentum B VGM
- YR Estimate
- 03/31/2023
- 03/31/2022
- 03/31/2021
- 03/31/2020
- 03/31/2019
- Revenue - Line of Business (LOBR)
- Revenue: U.S. Pharmaceutical
- 240,616.00
- 212,149.00
- 189,274.00
- 183,341.00
- 167,763.00
- Revenue - Line of Business (LOBR)
- Revenue: Prescription Technology Solutions
- 4,387.00
- 3,864.00
- 2,890.00
- 2,705.00
- 2,489.00
- Revenue - Line of Business (LOBR)
- Revenue: Medical-Surgical Solutions
- 11,110.00
- 11,608.00
- 10,099.00
- 8,305.00
- 7,618.00
- Revenue - Line of Business (LOBR)
- Revenue: International
- 20,598.00
- 36,345.00
- 35,965.00
- 38,341.00
- 38,023.00
- Income - Line of Business (LOBI)
- Adjusted Operating Profit: U.S. Pharmaceutical
- 3,106.00
- 2,879.00
- 2,717.00
- 2,671.00
- 2,520.00
- Income - Line of Business (LOBI)
- Adjusted Operating Profit: Prescription Technology Solutions
- 679.00
- 500.00
- 467.00
- 468.00
- --
- Income - Line of Business (LOBI)
- Adjusted Operating Profit: Medical-Surgical Solutions
- 1,159.00
- 959.00
- 805.00
- 679.00
- 605.00
- Income - Line of Business (LOBI)
- Adjusted Operating Profit: International
- 498.00
- -968.00
- 485.00
- 231.00
- 219.00
- Income - Line of Business (LOBI)
- Adjusted Operating Profit: Corporate
- -457.00
- -1,073.00
- -584.00
- -685.00
- -555.00